摘要
目的探讨生长抑制因子3(ING3)在原发性肝癌中的表达和意义。方法免疫组织化学检测105例原发性肝癌组织中ING3的表达Kendall’stan法进行相关性分析;Kaplan-Meier法绘制生存曲线,采用Log-rank检验分析;Cox比例风险回归模型分析独立预后影响因素。结果与癌旁组织比较,ING3在肝癌组织中低表达。肝癌组织中ING3低表达与肝癌肿瘤数量、分化程度、巴塞罗那临床肝癌分期标准(BCLC)、TNM分期、有无静脉浸润和有无“卫星”结节等临床病理因素之间有显著相关性(P〈0.05),而与患者性别、年龄等其他临床病理因素之间无明显相关(P〉0.05)。Cox回归分析显示ING3低表达是肝癌患者总生存率的独立影响因素[风险比(HR):2.742;95%可信区间(CI):1.270~9.959,P〈0.01],也是患者无复发生存的独立影响因素(HR:1.724;95%CI:0.856~3.940,P〈0.01)。Kaplan-Meier生存分析表明,与ING3高表达的患者比较,ING3低表达的患者总体生存(P〈0.05)和无复发生存均较差(P〈0.05)。结论ING3的表达降低参与原发性肝癌的发生发展,是原发性肝癌的独立预后影响因素。
Objective To investigated the expression of inhibitor of growth 3 ( ING3 ) and its clin- ieopathological significance in primary hepatoeellular carcinoma. Methods Immunohistochemistry was employed to detect the expression of ING3 in primary hepatoeellular carcinoma tissues of 105 patients. Cor- relation between variables was analyzed by Kendall' s tan method. Survival curves were plotted using Kap- lan - Meier method with Log - rank test. Cox proportional hazard model was used to evaluate the independ- ent prognostic factors. Results Compared with paracancerous tissues the expression level of ING3 de- creased in tumor tissues. Low expression of ING3 significantly correlated with the clinical parameters inclu- ding tumor number, differentiation, Barcelona Clinical Liver Classification (BCLC) , TNM stage, venous invasion, satellite nodules ( P 〈 0. 05 ), and showed no significant correlation with other clinical parameters including age, sex and so on. Cox regression analysis indicated that ING3 expression was independently in- fluencing factor of overall survival [ hazard ratio (HR) : 2. 742 ; 95% confidence interval (CI) : 1. 270 - 9. 959 ; P 〈 0.01 ] and recurrence - free survival ( HR : 1. 724 ; 95 % CI: 0. 856 - 3. 940 ; P 〈 0. 01 ) in liver cancer patients. Kaplan - Meier survival analysis showed that patients with low ING3 expression had poorer overall survival ( P 〈 0. 05) and poorer recurrence - free survival ( P 〈 0. 05 ) than those with high ING3 expression. Conclusion Low expression of ING3 took part in the development of primary hepatocel- lular carcinoma, and was independent prognostic factor in primary liver cancer patients.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2015年第10期2395-2398,共4页
Chinese Journal of Experimental Surgery
关键词
生长抑制因子3
肝癌
复发
预后
Inhibitor of growth 3
Hepatocellular cancer
Recurrence
Prognosis